Previous 10 | Next 10 |
2024-01-08 16:17:29 ET More on Bausch + Lomb Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch + Lomb Corporation (BLCO) Q3 2023 Earnings Call Transcript Bausch + Lomb wins FDA nod for eye surgery product Bausch + Lomb Non-GAAP EPS of $0.22 beat...
2024-01-08 13:53:28 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...
2024-01-08 08:31:17 ET More on Bausch Health, Bausch + Lomb, etc. Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch re...
First Excimer Platform Approved in Nearly Two Decades Offers Accuracy, Efficiency and Usability Advantages Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. Food and Drug Admi...
2024-01-06 13:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat with investors at the 42 nd Annual J.P. Morgan Healthcare Conference ...
2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...
2023-12-10 22:56:31 ET Summary Carl Icahn's 13F filing decreased from 15 to 14 holdings this quarter. The top five holdings in the filing are Icahn Enterprises, CVR Energy, Occidental Petroleum warrants, Southwest Gas Holdings, and FirstEnergy. Icahn disposed of his stake in X...
2023-12-10 17:00:00 ET Summary National Vision Holdings has experienced a decline in stock price due to the termination of its partnership with Walmart. Despite mixed financial performance, the company has a plan to recoup losses and it offers investors upside potential. The s...
2023-11-30 05:33:24 ET Summary Bausch Health has a solid business model with steady revenue generation and strong operating income margins - but debt & litigation are crippling the business. The company's heavy debt of >$20bn, and pending litigation around lead product Xifa...
News, Short Squeeze, Breakout and More Instantly...
Bausch + Lomb Corporation Company Name:
BLCO Stock Symbol:
NYSE Market:
Bausch + Lomb Corporation Website:
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2024 financial results on Wednesday, July 31, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to dis...
New Online Resource, KnowYourDryEye.com, Aims to Increase Awareness and Education Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today shared results from the company’s inaugural State of Dr...
Events Include Symposium on Patient-Centric Approaches to Dry Eye, Highlighting Breakthroughs in Diagnosis, Treatment and Care Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the pre...